CLINICAL_TRIALS
trial_result
· 2011-09-29
Clinical Trial Update: Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis [Phase 4]
Summary
A Phase 4 study evaluating the optimal combination of methotrexate and adalimumab for early rheumatoid arthritis; results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-09-29